Dr. Laurie Sutton

Assistant Professor · Tenure-Track

Department of Biological Sciences

College of Natural and Mathematical Sciences

She/Her/Hers/Herself

About

I am a neuroscientist and pharmacologist whose work spans from the cellular actions of neuropsychiatric drugs to the circuit-level mechanisms by which opioid systems shape mood and motivation. I received my B.S. in Biochemistry from the University of Waterloo and completed my Ph.D. in Cell Biology at the University of Western Ontario, where I investigated the cellular mechanisms of antipsychotic drugs. I then pursued postdoctoral training with Dr. Marc Caron at Duke University and Dr. Kirill Martemyanov in the Neuroscience Department at The Scripps Research Institute. During this time, my research uncovered a behavioral role for the orphan G protein–coupled receptor GPR158 in depression-related phenotypes. My laboratory now investigates how activation of the opioid system induces dysphoria and aversive responses, with the goal of understanding how neuromodulatory circuits contribute to affective state and motivated behavior.

Research interests

My laboratory investigates how opioid signaling induces dysphoric and aversive states, with the goal of elucidating how this neuromodulatory system shapes emotion and affective behaviors.

Teaching interests

Cell biology, Neuroscience

Education

  • Ph D, Anatomy and Cell Biology — University of Western Ontario (2011)
    Regulation of Akt and Wnt signalling by the dopamine D2 receptor and metabotropic glutamate receptor 2/3
  • MS, Anatomy and Cell Biology — University of Western Ontario (2005)
  • BS, Biochemistry — University of Waterloo (2003)

Publications

  • NF1-cAMP signaling dissociates cell type-specific contributions of striatal medium spiny neurons to reward valuation and motor control. 2019 PLoS biology · 17 (10) · pp. e3000477 Laurie Sutton, B S Muntean, O Ostrovskaya, S Zucca, M Dao, C Orlandi, C Song, K Xie, K A Martemyanov
  • The signaling proteins GPR158 and RGS7 modulate excitability of L2/3 pyramidal neurons and control A-type potassium channel in the prelimbic cortex. 2019 The Journal of biological chemistry · 294 (35) · pp. 13145-13157 C Song, C Orlandi, Laurie Sutton, K A Martemyanov
  • Homeostatic cAMP regulation by the RGS7 complex controls depression-related behaviors. 2019 Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 44 (3) · pp. 642-653 C Orlandi, Laurie Sutton, B S Muntean, C Song, K A Martemyanov
  • Orphan receptor GPR158 controls stress-induced depression. 2018 eLife · 7 Laurie Sutton, C Orlandi, C Song, W C Oh, B S Muntean, K Xie, A Filippini, X Xie, R Satterfield, Yaeger JDW, K J Renner, S M Young, Jr, B Xu, H Kwon, K A Martemyanov
  • NF1 Is a Direct G Protein Effector Essential for Opioid Signaling to Ras in the Striatum. 2016 Current biology : CB · 26 (22) · pp. 2992-3003 K Xie, L A Colgan, M T Dao, B S Muntean, Laurie Sutton, C Orlandi, S L Boye, S E Boye, C C Shih, Y Li, B Xu, R G Smith, R Yasuda, K A Martemyanov
  • Regulator of G-Protein Signaling 7 Regulates Reward Behavior by Controlling Opioid Signaling in the Striatum. 2016 Biological psychiatry · 80 (3) · pp. 235-45 Laurie Sutton, O Ostrovskaya, M Dao, K Xie, C Orlandi, R Smith, S Wee, K A Martemyanov
  • Essential role of D1R in the regulation of mTOR complex1 signaling induced by cocaine. 2015 Neuropharmacology · 99 · pp. 610-9 Laurie Sutton, M G Caron